<?xml version="1.0" encoding="UTF-8"?>
<p id="par0005">Coronavirus (COVID-19) infection and the mortality associated with the acute respiratory distress syndrome (hereafter referred to as ARDS) poses a global public health challenge.
 <xref rid="bib0145" ref-type="bibr">
  <sup>1</sup>
 </xref> To date, it exceeds two and a half million infections worldwide with a mortality rate that is greater than 7.08%. The increase in the spread and associated mortality poses a scenario where cost-effective therapeutic options to control the epidemic and decrease the number of deaths are urgently recommended to the international scientific community. Several reports show that the common final event that increases mortality from COVID-19 infection is ARDS, which results from an unmodulated inflammatory response and leads to death.
 <xref rid="bib0145" ref-type="bibr">1</xref>, 
 <xref rid="bib0150" ref-type="bibr">2</xref>
</p>
